Clinical Trials · NCT03466216
Phase 1 Study of AlphaMedix™ in Adult Subjects With SSTR (+) NET
- Phase
- Phase 1
- Recruitment status
- Terminated
- Sponsor
- Orano Med LLC
- Enrollment
- 33
- Start date
- Feb 2018
- Locations
- 1 site, United States
- Primary endpoint
- To determine dose-limiting toxicity (DLT)